Trial intelligence / Profile preview

TRAPP: Tranexamic Acid for PPH in Placenta Previa

NCT05811676Phase 3Completed

Sponsor
Guangzhou Medical University
Start
Jul 2023
Primary completion
Feb 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in postpartum hemorrhage (PPH) comparing Tranexamic Acid with Placebo (2 arms). Primary endpoint: Incidence of Postpartum Hemorrhage at Day 2. Started Jul 2023; status: completed.

02

Drugs

tranexamic acid
03

Conditions

postpartum hemorrhage (PPH)

Beyond the preview

Go deeper on NCT05811676.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05811676.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call